The Bristol Myers Squibb Foundation

The Bristol Myers Squibb Foundation advances health equity for disadvantaged populations around the world. 

A Legacy of Impact

For more than 20 years, the Bristol Myers Squibb Foundation has been leading the way in addressing the world’s most devastating challenges in healthcare. Its programs have saved hundreds of thousands of lives, transformed the standard of care in hundreds of low-income communities, and created sustainable and replicable models for the equitable delivery of quality healthcare. 

Our Mission


Focusing on communities most at risk of suffering the impacts of serious diseases in regions of the world that are hardest hit, the Bristol Myers Squibb Foundation empowers partners to develop and test innovative solutions to advance health equity and improve access to quality healthcare for patients. Grantmaking focuses on cancer, cardiovascular disease, and immunologic disease, as well as clinical trial diversity in the United States, and prevalent cancers in nine countries in Africa, Brazil and China.

The mission of the Bristol Myers Squibb Foundation is to promote health equity and improve the health outcomes of populations disproportionately affected by serious diseases by strengthening healthcare worker capacity, integrating medical care and community-based supportive services and mobilizing communities in the fight against disease. 

United States

  • Lung cancer 
  • Prostate cancer 
  • Multiple myeloma 
  • Breast cancer 
  • Deep vein thrombosis 
  • Atrial fibrillation 
  • Stroke 
  • Rheumatoid arthritis 
  • Multiple sclerosis 
  • Diversity in clinical trials



  • Lung cancer 
  • Multiple myeloma
  • Cervical cancer
  • Childhood cancers and blood disorders 


  • Lung cancer  
  • Melanoma 



  • Lung cancer
  • Gastric cancer
  • Liver cancer